Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Adverse Drug Event|Colon Cancer|Breast Cancer|Pancreas Cancer|Rectal Cancer|Gastric Cancer|Oesophageal Cancer|Bile Duct Cancer
Interventions: GENETIC: DPYD genotype
Sponsor: University of Southern Denmark
Collaborators: Odense University Hospital